Kopran Share Price

Kopran Share Price

NSE: KOPRAN
|
Pharmaceuticals
|
S Cap
₹ 181.15
+₹8.62 (5.00%)
1D
Last updated 13 Aug, 2026, 15:50 IST

Kopran Share Price Today

As of 14 Aug 2026, Kopran share price is ₹181.15. The stock opened at ₹172.50, compared to its previous close of ₹172.53. During today's trading session, Kopran share price moved in the range of ₹172.50 to ₹181.15, with an average price of ₹176.82 for the day. Looking at its last 52-week, the stock has touched a low of ₹107.00 and a high of ₹219.00. On the performance front, Kopran share price has increased by 35.03% over the last six months and is up 14.65% on a year-on-year basis.


₹172.50
5.00% up today
₹181.15
1D LOW
1D HIGH

Kopran Returns Calculator


Circuit
L
H
₹163.91
₹181.15
52-week
L
H
₹107.00
₹219.00

About Kopran

Kopran Share Price
ISIN
INE082A01010
Sector Market Cap
₹ 832.93 Cr

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Kopran Financial Highlights

  • Revenue: Kopran reported revenue of ₹681.77 crore in FY26 vs ₹633.58 crore in FY25. It showed an increase of 7.61% on a yearly basis.
  • Operating Profit: Kopran reported an operating profit of ₹34.36 crore in FY26 vs ₹51.95 crore in FY25. It showed a decrease of 33.86% on a year-on-year basis.
  • Net Profit: Kopran reported a net profit of ₹25.73 crore in FY26 vs ₹38.55 crore in FY25. It showed a decrease of 33.26% on a yearly basis.

Kopran Quarterly Result Highlights

  • Kopran reported revenue of ₹156.04 crore in Jun 2026, compared with ₹234.11 crore in Mar 2026, representing a decrease of 33.35% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported an operating profit of ₹8.80 crore in Jun 2026, compared with ₹25.35 crore in Mar 2026, representing a decrease of 65.29% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported a profit of ₹6.70 crore in Jun 2026, compared with ₹18.87 crore in Mar 2026, reflecting a decrease of 64.49% on a QoQ basis.
  • The earnings per share (EPS) of Kopran stood at ₹5.33 during Jun 2026.
Know more
Promoters
44.42%
FII
0.51%
Other DII
0.00%
Retail and other
55.06%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.60%
Dec 20250.36%
Mar 20260.57%
Jun 20260.51%
Mkt Cap Cr
832.93

P/E
33.37

P/B
1.57

ROE
4.85%

D/E
0.10

ROCE
6.56%

Div. Yield
1.66%

EPS(TTM)
6.30
Turnover
0.52

EV/EBITDA
15.55

Net Margin
9.95%

Op. Margin
16.22%

ROA
2.75%

Quick Ratio
1.19

Curr. Ratio
2.32
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Kopran has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Kopran appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Kopran earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,64,271.0038.325.5613.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,26,843.0077.5513.5315.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,000.0086.2722.1225.49%1.6913.85%222.760.69%0.4958.70
Zydus Lifesciences1,20,099.0026.154.4318.59%0.3117.35%237.300.08%0.3335.38
Cipla1,18,027.0035.183.4311.27%0.0014.95%423.360.89%0.4543.52
Lupin1,03,549.0018.654.6123.76%0.0424.88%659.050.79%0.57129.18
Mankind Pharma1,00,137.0048.436.1411.74%0.3413.13%397.020.04%0.4449.37
Dr. Reddy's Laboratories1,00,073.0031.442.6311.07%0.1812.54%377.960.67%0.4138.68
Laurus Labs99,474.2091.2318.7716.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,700.6026.062.559.25%0.1911.76%391.140.24%0.3841.58

Kopran Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹681.42₹629.60₹614.59₹550.99
Other Income₹0.35₹3.98₹14.61₹3.07
Total Revenue₹681.77₹633.59₹629.20₹554.05
Total Expenses₹647.41₹581.64₹561.66₹517.99
Profit Before Tax₹34.36₹51.95₹67.54₹36.07
Tax₹8.63₹13.40₹16.59₹8.83
Profit After Tax₹25.73₹38.55₹50.96₹27.23
EPS - Basic₹5.33₹7.99₹10.57₹5.65
EPS - Diluted₹5.33₹7.99₹10.57₹5.65

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹51.95₹67.54₹36.07₹81.78
Income before WC changes₹76.75₹88.50₹52.36₹95.60
Change in Assets-₹39.13-₹37.47-₹73.13-₹89.48
Change in Liabilities₹17.57₹6.55₹67.58-₹21.33
Change in WC-₹21.56-₹30.91-₹5.55-₹110.81
Cash flow from Operations₹41.94₹43.26₹34.02-₹33.48
Cash flow from Investing-₹56.43-₹43.55-₹12.65-₹84.42
Cash flow from Financing₹25.87₹0.99-₹19.84₹122.82
Total Cash Flow₹11.38₹0.69₹1.53₹4.93
Cash (Start of the year)₹8.09₹7.40₹5.87₹0.94
Cash (End of the year)₹19.47₹8.09₹7.40₹5.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹385.19₹334.26₹289.22₹250.63
Current Assets₹523.18₹509.75₹454.03₹399.07
Total Assets₹908.36₹844.01₹743.25₹649.70
Current Liabilities₹346.18₹288.97₹218.53₹176.97
Net Current Asset₹177.00₹220.78₹235.50₹222.10
Non-Current Liabilities₹31.90₹36.70₹33.47₹33.48
Equity Capital₹530.28₹518.35₹491.25₹439.25
Total Equity & Liabilities₹908.36₹844.01₹743.25₹649.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹305.65₹271.01₹337.46₹273.09
Other Income₹2.00₹5.90₹16.71₹16.09
Total Revenue₹307.65₹276.91₹354.17₹289.18
Total Expenses₹267.25₹241.12₹309.65₹252.27
Profit Before Tax₹40.39₹35.79₹44.52₹36.92
Tax₹9.99₹8.94₹9.88₹5.66
Profit After Tax₹30.40₹26.86₹34.64₹31.25
EPS - Basic₹6.30₹5.57₹7.18₹6.48
EPS - Diluted₹6.30₹5.57₹7.17₹6.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹35.79₹44.52₹36.92₹16.16
Income before WC changes₹42.38₹47.20₹27.87₹20.33
Change in Assets-₹5.26₹8.36-₹39.24-₹41.63
Change in Liabilities-₹3.73-₹10.77₹34.55-₹12.90
Change in WC-₹8.99-₹2.41-₹4.68-₹54.53
Cash flow from Operations₹23.30₹34.96₹16.87-₹37.80
Cash flow from Investing-₹15.41-₹6.27₹10.05-₹100.26
Cash flow from Financing₹5.64-₹24.08-₹26.13₹137.99
Total Cash Flow₹13.53₹4.61₹0.79-₹0.07
Cash (Start of the year)₹5.65₹1.04₹0.25₹0.32
Cash (End of the year)₹19.18₹5.65₹1.04₹0.25

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹365.65₹337.44₹323.17₹315.54
Current Assets₹240.24₹209.05₹187.70₹190.41
Total Assets₹605.89₹546.48₹510.88₹505.95
Current Liabilities₹146.94₹103.33₹84.54₹100.88
Net Current Asset₹93.29₹105.72₹103.16₹89.53
Non-Current Liabilities₹11.12₹11.72₹9.47₹9.48
Equity Capital₹447.83₹431.44₹416.87₹395.59
Total Equity & Liabilities₹605.89₹546.48₹510.88₹505.95
* All values are in INR Crore
Qty
Bid
16400
181.15
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 16400
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
32.57
Neutral

ATR (14)
9
Neutral

STOCH(9,6)
20.73
Bullish

STOCH RSI (14)
0
Bullish

ADX(9)
44.9
Bearish

UO(9)
52.71
Neutral

ROC(12)
-14.25
Bearish

WillR(14)
-82.82
Bullish
Period
Simple value
Exponential vaue

5D
177.39
179.33

10D
184.39
183.21

20D
191.64
187.72

50D
190.9
186.66

100D
172.69
176.29
Volume trend — traded volume by day
13 Aug1L
12 Aug0L
11 Aug1L
10 Aug1L
7 Aug2L
Average1L
Compare against other stocks
Kopran Share Price
Kopran
Pharmaceuticals
Add Stock
Add Another

Kopran Share Price FAQs